Clinical Usefulness of the 2010 Clinical and Laboratory Standards Institute Revised Breakpoints for Cephalosporin Use in the Treatment of Bacteremia Caused by <i>Escherichia coli</i> or <i>Klebsiella</i> spp.

<div>Flowchart of patient inclusion and subsequent treatment.</div>

BioMed Research International

fig1

Figure 1

Figure 1: Clinical Usefulness of the 2010 Clinical and Laboratory Standards Institute Revised Breakpoints for Cephalosporin Use in the Treatment of Bacteremia Caused by <i>Escherichia coli</i> or <i>Klebsiella</i> spp. 

Figure 1 | Clinical Usefulness of the 2010 Clinical and Laboratory Standards Institute Revised Breakpoints for Cephalosporin Use in the Treatment of Bacteremia Caused by Escherichia coli or Klebsiella spp. 